日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses

挽救性纳武利尤单抗单药治疗晚期食管鳞状细胞癌的疗效和安全性:240 mg 与 480 mg 剂量的比较

Murashima, Yuko; Yamamoto, Shun; Hirose, Toshiharu; Kadono, Toru; Ikeda, Go; Ohara, Akihiro; Itoyama, Mai; Yokoyama, Kazuki; Honma, Yoshitaka; Ishiyama, Koshiro; Oguma, Jyunya; Daiko, Hiroyuki; Kato, Ken

Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin

FOLFOX方案术前治疗对不适合接受顺铂治疗的可切除食管鳞状细胞癌患者的安全性和短期疗效

Kadono, Toru; Yamamoto, Shun; Hirose, Toshiharu; Ikeda, Go; Ohara, Akihiro; Itoyama, Mai; Yokoyama, Kazuki; Honma, Yoshitaka; Hashimoto, Taiki; Sekine, Shigeki; Ishiyama, Koshiro; Oguma, Junya; Daiko, Hiroyuki; Kato, Ken

Hyperthermia maintains death receptor expression and promotes TRAIL-induced apoptosis

高温维持死亡受体表达并促进 TRAIL 诱导的细胞凋亡

Go Ohara, Kazuto Okabe, Naoto Toyama, Yuya Ohta, Song Xinman, Norihisa Ichimura, Kotaro Sato, Yusuke Urata, Hideharu Hibi